Company Filing History:
Years Active: 2017-2023
Title: The Innovations of Jeffrey Ming
Introduction
Jeffrey Ming is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of asthma. With a total of 2 patents to his name, his work has the potential to impact many lives.
Latest Patents
Ming's latest patents focus on innovative methods for treating or preventing asthma. One of his notable inventions involves administering an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody, to patients in need. This therapeutic composition aims to provide relief from asthma and associated conditions, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Jeffrey Ming has worked with prominent companies in the biotechnology sector. He has been associated with Sanofi Biotechnology and Regeneron Pharmaceuticals, Inc., where he has contributed to various research initiatives. His experience in these organizations has helped him refine his skills and expand his knowledge in the field.
Collaborations
Ming has collaborated with several professionals in his field, including Marius Ardeleanu and Namita A Gandhi. These partnerships have allowed him to enhance his research and develop innovative solutions for asthma treatment.
Conclusion
Jeffrey Ming's contributions to asthma treatment through his patents and collaborations highlight his dedication to improving healthcare. His work continues to inspire advancements in medical science and offers hope for those affected by asthma.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.